Novel aspects of macromolecular repair and relationship to human disease

Journal of Molecular Medicine

Volumn 82, Issue 5, 2004, Pages 280-297

  Krokan, Hans E ^a,b,c,d   Kavli, Bodil ^a   Slupphaug, Geir ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d Norwegian Univ of Sci and Technol ^*

Author keywords

Cellular defence; DNA repair; Immunity; Protein repair; RNA repair

Indexed keywords

AMINO ACID; ANTIGEN; ASPARAGINE; ASPARTIC ACID; DNA; DNA GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ISOASPARTIC ACID; ISOENZYME; METHIONINE SULFOXIDE; METHIONINE SULFOXIDE REDUCTASE; RNA; URACIL;

ALLELE; ALZHEIMER DISEASE; ANTIBODY AFFINITY; BREAST CARCINOMA; CANCER PREVENTION; CELL CYCLE; CELL DEATH; CELLULAR IMMUNITY; COLON CARCINOMA; COMPLEX FORMATION; CYTOTOXICITY; DEAMINATION; DEGENERATIVE DISEASE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; EPILEPSY; EXCISION REPAIR; EXPOSURE; FAMILIAL CANCER; GENETIC CODE; HUMAN; HUMORAL IMMUNITY; HUNTINGTON CHOREA; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION PREVENTION; ISOMERIZATION; MACROMOLECULE; MAMMAL; METHYLATION; MISMATCH REPAIR; MUTATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; POLYPOSIS; PROTEIN DENATURATION; PROTEIN FOLDING; RETROVIRUS INFECTION; REVIEW; RISK FACTOR; SEQUENCE HOMOLOGY; SOMATIC HYPERMUTATION; SURVIVAL RATE; XERODERMA PIGMENTOSUM;

AMINO ACIDS; DISEASE; DNA DAMAGE; DNA REPAIR; ESCHERICHIA COLI PROTEINS; HUMANS; IMMUNITY, ACTIVE; MIXED FUNCTION OXYGENASES; MOLECULAR STRUCTURE; RNA;

EID: 2542476302     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0528-1     Document Type: Review

References (170)

1. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366-374
2. Lindahl T, Wood RD (1999) Quality control by DNA repair. Science 286:1897-1905
3. Mellon I, Hanawalt PC (1989) Induction of the Escherichia coli lactose operon selectively increases repair of its transcribed DNA strand. Nature 342:95-98
4. Hanawalt PC (2002) Subpathways of nucleotide excision repair and their regulation. Oncogene 21:8949-8956
5. Guzder SN, Sung P, Prakash L, Prakash S (1996) Nucleotide excision repair in yeast is mediated by sequential assembly of repair factors and not by a pre-assembled repairosome. J Biol Chem 271:8903-8910
6. Riedl T, Hanaoka F, Egly JM (2003) The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J 22:5293-5303
7. Friedberg EC (2001) How nucleotide excision repair protects against cancer. Nat Rev Cancer 1:22-33
8. Green CM, Almouzni G (2002) When repair meets chromatin. EMBO Rep 3:28-33
9. Rubbi CP, Milner J (2003) p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J 22:975-986
10. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, Bootsma D, Hoeijmakers JH (1998) Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 2:223-232
11. Ng JM, Vermeulen W, van der Horst GT, Bergink S, Sugasawa K, Vrieling H, Hoeijmakers JH (2003) A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilisation of xeroderma pigmentosum group C protein. Genes Dev 17:1630-1645
12. Adimoolam S, Ford JM (2003) p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair 2:947-954
13. Green CM, Almouzni G (2003) Local action of the chromatin assembly factor CAF-1 at sites of nucleotide excision repair in vivo. EMBO J 22:5163-5174
14. Lindahl T (1993) Instability and decay of the primary structure of DNA. Nature 362:709-715
15. Krokan HE, Standal R, Slupphaug G (1997) DNA glycosylases in the base excision repair of DNA. Biochem J 325:1-16
16. Krokan HE, Nilsen H, Skorpen F, Otterlei M, Slupphaug G (2000) Base excision repair of DNA in mammalian cells. FEBS Lett 476:73-77
17. Krokan HE, Drablos F, Slupphaug G (2002) Uracil in DNA-occurrence, consequences and repair. Oncogene 21:8935-8948
18. Scharer OD, Jiricny J (2001) Recent progress in the biology, chemistry and structural biology of DNA glycosylases. Bioessays 23:270-281
19. Slupphaug G, Kavli B, Krokan HE (2004) The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res (in press)
20. Slupphaug G, Mol CD, Kavli B, Arvai AS, Krokan HE, Tainer JA (1996) A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA. Nature 384:87-92
21. Fromme JC, Verdine GL (2003) DNA lesion recognition by the bacterial repair enzyme MutM. J Biol Chem 278:51543-51548
22. Eichman BF, O'Rourke EJ, Radicella JP, Ellenberger T (2003) Crystal structures of 3-methyladenine DNA glycosylase MagIII and the recognition of alkylated bases. EMBO J 22:4898-4909
23. Fromme JC, Verdine GL (2003) Structure of a trapped endonuclease III-DNA covalent intermediate. EMBO J 22:3461-3471
24. Norman DP, Chung SJ, Verdine GL (2003) Structural and biochemical exploration of a critical amino acid in human 8-oxoguanine glycosylase. Biochemistry 42:1564-1572
25. Nilsen H, Lindahl T, Verreault A (2002) DNA base excision repair of uracil residues in reconstituted nucleosome core particles. EMBO J 21:5943-5952
26. Memisoglu A, Samson L (2000) Base excision repair in yeast and mammals. Mutat Res 451:39-51
27. Dianov GL, O'Neill P, Goodhead DT (2001) Securing genome stability by orchestrating DNA repair: removal of radiation-induced clustered lesions in DNA. Bioessays 23:745-749
28. Hosfield DJ, Daniels DS, Mol CD, Putnam CD, Parikh SS, Tainer JA (2001) DNA damage recognition and repair pathway coordination revealed by the structural biochemistry of DNA repair enzymes. Prog Nucleic Acid Res Mol Biol 68:315-347
29. Matsumoto Y (2001) Molecular mechanism of PCNA-dependent base excision repair. Prog Nucleic Acid Res Mol Biol 68:129-138
30. Dogliotti E, Fortini P, Pascucci B, Parlanti E (2001) The mechanism of switching among multiple BER pathways. Prog Nucleic Acid Res Mol Biol 68:3-27
31. Dianov GL, Souza-Pinto N, Nyaga SG, Thybo T, Stevnsner T, Bohr VA (2001) Base excision repair in nuclear and mitochondrial DNA. Prog Nucleic Acid Res Mol Biol 68:285-297
32. Sokhansanj BA, Rodrigue GR, Fitch JP, Wilson DM III (2002) A quantitative model of human DNA base excision repair. I. Mechanistic insights. Nucleic Acids Res 30:1817-1825
33. Mitra S, Izumi T, Boldogh I, Bhakat KK, Hill JW, Hazra TK (2002) Choreography of oxidative damage repair in mammalian genomes. Free Radic Biol Med 33:15-28
34. Bhattacharyya N, Chen HC, Comhair S, Erzurum SC, Banerjee S (1999) Variant forms of DNA polymerase beta in primary lung carcinomas. DNA Cell Biol 18:549-554
35. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z (2003) DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 95:1312-1319
36. Wilson DM III, Thompson LH (1997) Life without DNA repair. Proc Natl Acad Sci USA 94:12754-12757
37. Engelward BP, Weeda G, Wyatt MD, Broekhof JL, de Wit J, Donker I, Allan JM, Gold B, Hoeijmakers JH, Samson LD (1997) Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci USA 94:13087-13092
38. Hang B, Singer B, Margison GP, Elder RH (1997) Targeted deletion of alkylpurine-DNA-N-glycosylase in mice eliminates repair of 1,N-6-ethenoadenine and hypoxanthine but not of 3,N4-ethenocytosine or 8-oxoguanine. Proc Natl Acad Sci USA 94:12869-12874
39. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T, Barnes DE (1999) Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 96:13300-13305
40. Nilsen H, Rosewell I, Robins P, Skjelbred CF, Andersen S, Slupphaug G, Daly G, Krokan HE, Lindahl T, Barnes DE (2000) Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol Cell 5:1059-1065
41. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H, Masumura K, Nohmi T, Nishimura S, Noda T (2000) Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci USA 97:4156-4161
42. Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, Clarke AR, Bird A (2002) Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297:403-405
43. Bentley DJ, Harrison C, Ketchen AM, Redhead NJ, Samuel K, Waterfall M, Ansell JD, Melton DW (2002) DNA ligase I-null mouse cells show normal DNA repair activity but altered DNA replication and reduced genome stability. J Cell Sci 115:1551-1561
44. Nilsen H, Stamp G, Andersen S, Hrivnak G, Krokan HE, Lindahl T, Barnes DE (2003) Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 22:5381-5386
45. Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol 12:1748-1755
46. Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4:1023-1028
47. Al Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP (2002) Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 30:227-232
48. Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR, Cheadle JP (2002) Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11:2961-2967
49. Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, Frayling I, Jordan S, Maher ER, Mak T, Maynard J, Pigatto F, Shaw J, Cheadle JP (2003) Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362:39-41
50. Slupska MM, Baikalov C, Luther WM, Chiang JH, Wei YF, Miller JH (1996) Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J Bacteriol 178:3885-3892
51. Parker A, Gu Y, Mahoney W, Lee SH, Singh KK, Lu AL (2001) Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair. J Biol Chem 276:5547-5555
52. Boldogh I, Milligan D, Lee MS, Bassett H, Lloyd RS, McCullough AK (2001) hMYH cell cycle-dependent expression, subcellular localisation and association with replication foci: evidence suggesting replication-coupled repair of adenine:8-oxoguanine mispairs. Nucleic Acids Res 29:2802-2809
53. Klungland A, Lindahl T (1997) Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J 16:3341-3348
54. Frosina G, Cappelli E, Fortini P, Dogliotti E (1999) In vitro base excision repair assay using mammalian cell extracts. Methods Mol Biol 113:301-315
55. Matsumoto Y, Kim K, Hurwitz J, Gary R, Levin DS, Tomkinson AE, Park MS (1999) Reconstitution of proliferating cell nuclear antigen-dependent repair of apurinic/apyrimidinic sites with purified human proteins. J Biol Chem 274:33703-33708
56. Pascucci B, Maga G, Hubscher U, Bjoras M, Seeberg E, Hickson ID, Villani G, Giordano C, Cellai L, Dogliotti E (2002) Reconstitution of the base excision repair pathway for 7,8-dihydro-8-oxoguanine with purified human proteins. Nucleic Acids Res 30:2124-2130
57. Sattler U, Frit P, Salles B, Calsou P (2003) Long-patch DNA repair synthesis during base excision repair in mammalian cells. EMBO Rep 4:363-367
58. Modrich P, Lahue R (1996) Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65:101-133
59. Palombo F, Iaccarino I, Nakajima E, Ikejima M, Shimada T, Jiricny J (1996) hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr Biol 6:1181-1184
60. Kolodner RD, Marsischky GT (1999) Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9:89-96
61. Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN (1996) Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272:557-560
62. D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, Jiricny J (1998) Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol 54:334-341
63. Wu J, Gu L, Wang H, Geacintov NE, Li GM (1999) Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis. Mol Cell Biol 19:8292-8301
64. Yanamadala S, Ljungman M (2003) Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates. Mol Cancer Res 1:747-754
65. Aquilina G, Bignami M (2001) Mismatch repair in correction of replication errors and processing of DNA damage. J Cell Physiol 187:145-154
66. Marti TM, Kunz C, Fleck O (2002) DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191:28-41
67. Chung DC, Rustgi AK (2003) The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 138:560-570
68. Jiricny J, Marra G (2003) DNA repair defects in colon cancer. Curr Opin Genet Dev 13:61-69
69. Peltomaki P (2003) Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 21:1174-1179
70. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027
71. Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113:1146-1158
72. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95:6870-6875
73. Claij N, Te RH (2002) Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level. Oncogene 21:2873-2879
74. Jackson SP (2001) Detecting, signalling and repairing DNA double-strand breaks. Biochem Soc Trans 29:655-661
75. Vilenchik MM, Knudson AG (2003) Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci USA 100:12871-12876
76. Bernstein C, Bernstein H, Payne CM, Garewal H (2002) DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511:145-178
77. Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-696
78. Bishop AJ, Schiestl RH (2003) Role of homologous recombination in carcinogenesis. Exp Mol Pathol 74:94-105
79. Mills KD, Ferguson DO, Alt FW (2003) The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 194:77-95
80. Valerie K, Povirk LF (2003) Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22:5792-5812
81. West SC (2003) Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol 4:435-445
82. Rothkamm K, Kruger I, Thompson LH, Lobrich M (2003) Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23:5706-5715
83. Allen C, Halbrook J, Nickoloff JA (2003) Interactive competition between homologous recombination and non-homologous end joining. Mol Cancer Res 1:913-920
84. Shiloh Y (2001) ATM and ATR: networking cellular responses to DNA damage. Curr Opin Genet Dev 11:71-77
85. Yang J, Yu Y, Hamrick HE, Duerksen-Hughes PJ (2003) ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. Carcinogenesis 24:1571-1580
86. Kojis TL, Gatti RA, Sparkes RS (1991) The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenet 56:143-156
87. Easton DF (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 66:S177-S182
88. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506
89. Welcsh PL, King MC (2001) BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10:705-713
90. Rubin H, Plotnick M, Wang ZM, Liu X, Zhong Q, Schechter NM, Cooperman BS (1994) Conversion of alpha 1-antichymotrypsin into a human neutrophil elastase inhibitor: demonstration of variants with different association rate constants, stoichiometries of inhibition, and complex stabilities. Biochemistry 33:7627-7633
91. Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA (2003) Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Exp Cell Res 289:211-221
92. Thyagarajan B, Campbell C (1997) Elevated homologous recombination activity in Fanconi anemia fibroblasts. J Biol Chem 272:23328-23333
93. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606-609
94. Doherty AJ, Jackson SP (2001) DNA repair: how Ku makes ends meet. Curr Biol 11:R920-R924
95. cs. EMBO J 22:5875-5882
96. Li L, Moshous D, Zhou Y, Wang J, Xie G, Salido E, Hu D, de Villartay JP, Cowan MJ (2002) A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J Immunol 168:6323-6329
97. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, de Villartay JP (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177-186
98. Lieber MR, Ma Y, Pannicke U, Schwarz K (2003) Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4:712-720
99. Mahajan KN, Nick-McElhinny SA, Mitchell BS, Ramsden DA (2002) Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol 22:5194-5202
100. Onclercq-Delic R, Calsou P, Delteil C, Salles B, Papadopoulo D, Amor-Gueret M (2003) Possible anti-recombinogenic role of Bloom's syndrome helicase in double-strand break processing. Nucleic Acids Res 31:6272-6282
101. German J, Ellis NA, Proytcheva M (1996) Bloom's syndrome. XIX. Cytogenetic and population evidence for genetic heterogeneity. Clin Genet 49:223-231
102. Schawalder JC, Paric E, Neff NF (2003) Telomere and ribosomal DNA repeats are chromosomal targets of the Bloom syndrome DNA helicase. BMC Cell Biol 4:15
103. Opresko PL, Cheng WH, von Kobbe C, Harrigan JA, Bohr VA (2003) Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis 24:791-802
104. Wang H, Zeng ZC, Perrault AR, Cheng X, Qin W, Iliakis G (2001) Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. Nucleic Acids Res 29:1653-1660
105. Bassing CH, Swat W, Alt FW (2002) The mechanism and regulation of chromosomal V(D)J recombination. Cell [Suppl] 109:S45-S55
106. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR (1996) RAG mutations in human B cell-negative SCID. Science 274:97-99
107. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563
108. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565-575
109. Durandy A, Honjo T (2001) Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr Opin Immunol 13:543-548
110. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274:18470-18476
111. Rada C, Ehrenstein MR, Neuberger MS, Milstein C (1998) Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9:135-141
112. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K, Hanaoka F (1999) The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399:700-704
113. Johnson RE, Kondratick CM, Prakash S, Prakash L (1999) hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285:263-265
114. Zeng X, Winter DB, Kasmer C, Kraemer KH, Lehmann AR, Gearhart PJ (2001) DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol 2:537-541
115. Reynaud CA, Aoufouchi S, Faili A, Weill JC (2003) What role for AID: mutator, or assembler of the immunoglobulin mutasome?. Nat Immunol 4:631-638
116. Barreto V, Reina-San-Martin B, Ramiro AR, McBride KM, Nussenzweig MC (2003) C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol Cell 12:501-508
117. Ta VT, Nagaoka H, Catalan N, Durandy A, Fischer A, Imai K, Nonoyama S, Tashiro J, Ikegawa M, Ito S, Kinoshita K, Muramatsu M, Honjo T (2003) AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4:843-848
118. Lecossier D, Bouchonnet F, Clavel F, Hance AJ (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112
119. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103
120. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809
121. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesised HIV-1 DNA. Nature 424:94-98
122. Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F (1987) The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893
123. Strebel K, Daugherty D, Clouse K, Cohen D, Folks T, Martin MA (1987) The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328:728-730
124. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650
125. Marin M, Rose KM, Kozak SL, Kabat D (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9:1398-1403
126. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407
127. Bellacosa A, Moss EG (2003) RNA repair: damage control. Curr Biol 13:R482-R484
128. Iordanov MS, Ryabinina OP, Wong J, Dinh TH, Newton DL, Rybak SM, Magun BE (2000) Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis. Cancer Res 60:1983-1994
129. Honjo E, Watanabe K, Tsukamoto T (2002) Real-time kinetic analyses of the interaction of ricin toxin A-chain with ribosomes prove a conformational change involved in complex formation. J Biochem 131:267-275
130. Yoshizawa S, Fourmy D, Puglisi JD (1999) Recognition of the codon-anticodon helix by ribosomal RNA. Science 285:1722-1725
131. Rozenski J, Crain PF, McCloskey JA (1999) The RNA modification database: 1999 update. Nucleic Acids Res 27:196-197
132. Singer B, Grunberger D (1983) Molecular biology of butagens and carcinogens. Plenum, New York
133. Falnes PO, Johansen RF, Seeberg E (2002) AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419:178-182
134. Trewick SC, Henshaw TF, Hausinger RP, Lindahl T, Sedgwick B (2002) Oxidative demethylation by Escherichia coli AIkB directly reverts DNA base damage. Nature 419:174-178
135. Aas PA, Otterlei M, Falnes PO, Vagbo CB, Skorpen F, Akbari M, Sundheim O, Bjoras M, Slupphaug G, Seeberg E, Krokan HE (2003) Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 421:859-863
136. Karimi-Busheri F, Weinfeld M (1997) Purification and substrate specificity of polydeoxyribonucleotide kinases isolated from calf thymus and rat liver. J Cell Biochem 64:258-272
137. Amitsur M, Levitz R, Kaufmann G (1987) Bacteriophage T4 anticodon nuclease, polynucleotide kinase and RNA ligase reprocess the host lysine tRNA. EMBO J 6:2499-2503
138. Wang LK, Lima CD, Shuman S (2002) Structure and mechanism of T4 polynucleotide kinase: an RNA repair enzyme. EMBO J 21:3873-3880
139. Reissner KJ, Aswad DW (2003) Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell Mol Life Sci 60:1281-1295
140. Robinson NE (2002) Protein deamidation. Proc Natl Acad Sci USA 99:5283-5288
141. Robinson, NE, Robinson AB (2001) Deamidation of human proteins. Proc Natl Acad Sci USA 98:12409-12413
142. Lindner H, Helliger W (2001) Age-dependent deamidation of asparagine residues in proteins. Exp Gerontol 36:1551-1563
143. Griffith SC, Sawaya MR, Boutz DR, Thapar N, Katz JE, Clarke S, Yeates TO (2001) Crystal structure of a protein repair methyltransferase from Pyrococcus furiosus with its L-isoaspartyl peptide substrate. J Mol Biol 313:1103-1116
144. Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG (1997) Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci USA 94:6132-6137
145. Yamamoto A, Takagi H, Kitamura D, Tatsuoka H, Nakano H, Kawano H, Kuroyanagi H, Yahagi Y, Kobayashi S, Koizumi K, Sakai T, Saito K, Chiba T, Kawamura K, Suzuki K, Watanabe T, Mori H, Shirasawa T (1998) Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J Neurosci 18:2063-2074
146. Solstad T, Carvalho RN, Andersen OA, Waidelich D, Flatmark T (2003) Deamidation of labile asparagine residues in the autoregulatory sequence of human phenylalanine hydroxylase. Eur J Biochem 270:929-938
147. Clarke S (2003) Aging as war between chemical and biochemical processes: Protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev 2:263-285
148. Lowenson JD, Kim E, Young SG, Clarke S (2001) Limited accumulation of damaged proteins in 1-isoaspartyl (D-aspartyl) o-methyltransferase-deficient mice. J Biol Chem 276:20695-20702
149. Payan IL, Chou SJ, Fisher GH, Man EH, Emory C, Frey WH (1992) Altered aspartate in Alzheimer neurofibrillary tangles. Neurochem Res 17:187-191
150. Johnson BA, Shirokawa JM, Geddes JW, Choi BH, Kim RC, Aswad DW (1991) ProteinL-isoaspartyl methyltransferase in postmortem brains of aged humans. Neurobiol Aging 12:19-24
151. Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T (2000) Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch Biochem Biophys 381:225-234
152. Shimizu T, Ikegami T, Ogawara M, Suzuki Y, Takahashi M, Morio H, Shirasawa T (2002) Transgenic expression of the protein-L-isoaspartyl methyltransferase (PIMT) gene in the brain rescues mice from the fatal epilepsy of PIMT deficiency. J Neurosci Res 69:341-352
153. Lanthier J, Bouthillier A, Lapointe M, Demeule M, Beliveau R, Desrosiers RR (2002) Down-regulation of proteinL-isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin. J Neurochem 83:581-591
154. Vogt W (1995) Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med 18:93-105
155. Brot N, Weissbach H (2000) Peptide methionine sulfoxide reductase: biochemistry and physiological role. Biopolymers 55:288-296
156. Hoshi T, Heinemann S (2001) Regulation of cell function by methionine oxidation and reduction. J Physiol (Lond) 531:1-11
157. Burk RF, Hill KE, Motley AK (2003) Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 133:1517S-1520S
158. Moskovitz J, Stadtman ER (2003) Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues. Proc Natl Acad Sci USA 100:7486-7490
159. Kuschel L, Hansel A, Schonherr R, Weissbach H, Brot N, Hoshi T, Heinemann SH (1999) Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA). FEBS Lett 456:17-21
160. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA 98:12920-12925
161. Ruan H, Tang XD, Chen ML, Joiner ML, Sun G, Brot N, Weissbach H, Heinemann SH, Iverson L, Wu CF, Hoshi T, Chen ML, Joiner MA, Heinemann SH (2002) High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 99:2748-2753
162. Petropoulos I, Mary J, Perichon M, Friguet B (2001) Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. Biochem J 355:819-825
163. Gabbita SP, Aksenov MY, Lovell MA, Markesbery WR (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem 73:1660-1666
164. Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-1858
165. Langer T, Rosmus S, Fasold H (2003) Intracellular localisation of the 90 kDa heat shock protein (HSP90alpha) determined by expression of a EGFP-HSP90 alpha-fusion protein in unstressed and heat stressed 3T3 cells. Cell Biol Int 27:47-52
166. Goetz MP, Toft DO, Ames MM, Erlichman C (2003) The Hsp90 chaperone complex as a novel target for cancer therapy. Ann Oncol 14:1169-1176
167. Mayer MP, Bukau B (1999) Molecular chaperones: the busy life of Hsp90. Curr Biol 9:R322-R325
168. Ben Zvi AP, Goloubinoff P (2001) Review: mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones. J Struct Biol 135:84-93
169. Naylor DJ, Hartl FU (2001) Contribution of molecular chaperones to protein folding in the cytoplasm of prokaryotic and eukaryotic cells. Biochem Soc Symp 68:45-68
170. Dobson CM (2001) Protein folding and its links with human disease. Biochem Soc Symp 68:1-26